Vaccination made good financial sense in addition to saving lives.
Still does.
Edited by Swati Mestri, reviewed by Robert Egan
Every dollar spent on COVID-19 vaccine development and
distribution generated an estimated $81 to $810 in economic value during the
first year that vaccines were given, according to new research published in the journal PLOS Medicine.
Dr. Fauci was right
The study—the first global analysis of the return on
investment for COVID-19 vaccines—shows that vaccines not only averted severe
illness and saved lives but were also a sound investment.
"Our study provides evidence that the unprecedented,
rapid investments made into COVID-19 vaccines early in the pandemic paid off
massively both in health and economic benefits," said study author Mark
Jit, professor of global health at NYU School of Global Public Health.
"Vaccine development, as well as equitable vaccine distribution globally,
should be prioritized before and during global health crises."
Counting costs beyond vaccine purchases
Vaccines played a critical role during the COVID-19
pandemic, but their development required extraordinary effort—and
spending—among governments, pharmaceutical companies and nonprofit
organizations. The resulting vaccines were highly effective at preventing
severe illness and death, with one study estimating that between 14 million
and 20 million deaths were averted in the first year that vaccines were
available.
Despite their health impact, the economic value of these
vaccines has not been examined on a global scale. Moreover, most analyses of
the cost-effectiveness of immunization look at the cost of purchasing the
vaccine itself from its manufacturer, not the cost of developing it.
"With other vaccines, a company takes on the risk by
investing its own money to develop a vaccine. But the COVID
vaccine was not purely a private sector decision—the U.S., the European
Union and other countries like China poured substantial funding into this to
reduce the risk for vaccine companies," said Jit. "We wanted to
understand how these costs compared to health and economic outcomes."

















.jpeg)





